Our results suggested that IL-26 promoted osteoclastogenesis in RA via two pathways: (1) direct effects associated with induced differentiation of osteoclast precursors and (2) indirect effects through increased RANKL expression in FLSs. Here, TNFSF11 is linked to rheumatoid arthritis.